Shares of Acadia Healthcare, a behavioral health company, experienced a significant decline of 9% during the afternoon trading session following the release of a disappointing forecast for its upcoming second quarter. The company’s projected revenue of approximately $842.5 million at the midpoint fell 2.7% short of analysts’ expectations, further compounded by its adjusted earnings per share guidance, which also misaligned with Wall Street forecasts.
In its first-quarter performance, Acadia reported a year-on-year revenue increase of 7.6%, totaling $828.8 million, and an adjusted earnings per share of $0.37, which exceeded expectations. However, these positive results were overshadowed by the discouraging outlook for the next quarter. Interestingly, the company’s adjusted earnings per share for the first quarter saw a decline from $0.40 in the same period last year.
The stock closed at $25.91, reflecting an 8.3% drop from its previous close. Market analysts are contemplating whether this downturn presents an opportunity for investors to acquire a quality stock at a lower price, highlighting that considerable price fluctuations may indicate market overreactions.
Acadia Healthcare has exhibited considerable volatility, with 33 moves greater than 5% in the past year. This latest drop suggests that the market regards the recent news as significant but not fundamentally detrimental to the company’s long-term outlook. A noteworthy previous incident occurred three months ago when the stock surged 24% after the announcement of leadership changes, including the return of former CEO Debra K. Osteen. Osteen’s earlier tenure from December 2018 to March 2022 was marked by successful turnaround efforts, nearly doubling the stock’s price during that period.
Despite the current decline, Acadia Healthcare has seen an impressive year-to-date gain of 81.3%, nearing its 52-week high of $28.26 from April 2026. However, a retrospective look reveals that investors who purchased $1,000 worth of shares five years ago would have experienced a substantial decrease in value, now worth only $425.23.
As Acadia reaffirms its full-year 2025 financial guidance amid leadership changes, analysts continue to weigh the company’s underlying stability against its recent forecast and historical performance to gauge potential future directions.
